Want to see SG:Y3D full AI Analyst Report?
Top Page
mDR Limited
(SGX:Y3D)
Select Model
Select Model
Rating:48Neutral
Price Target:
S$0.04
▼(-35.00% Downside)
Action:Reiterated
Date:07/01/26
The score is primarily weighed down by weakening financial performance—especially the sharp drop in operating/free cash flow and increased leverage—alongside a clear downtrend versus key moving averages. Valuation is a relative positive due to the moderate P/E and high dividend yield, but it is not enough to offset the fundamental and technical weakness.
Positive Factors
Revenue Resilience
Consistent year-over-year revenue growth into 2025 demonstrates underlying demand for the company’s distribution services. A stable top line provides a base to absorb cost pressures, supports operational leverage if margins recover, and reduces strategic risk tied to shrinking market demand.
Negative Factors
Rising Leverage
A doubling of debt materially increases financial risk and interest obligations. Debt/equity moved to ~0.82 from 0.36, constraining strategic flexibility. Higher leverage limits ability to invest, raises refinancing risk in stress, and amplifies earnings volatility effects on shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Resilience
Consistent year-over-year revenue growth into 2025 demonstrates underlying demand for the company’s distribution services. A stable top line provides a base to absorb cost pressures, supports operational leverage if margins recover, and reduces strategic risk tied to shrinking market demand.
Read all positive factors
mDR Limited (Y3D) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$85.85M
Dividend Yield4.1%
Average Volume (3M)659.92K
Price to Earnings (P/E)―
Beta (1Y)0.99
Revenue Growth6.95%
EPS Growth-113.73%
CountrySG
Employees241
SectorTechnology
Sector Strength88
IndustryTechnology Distributors
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,357,261,200
10 Day Avg. Volume214,570
30 Day Avg. Volume659,923
Financial Highlights & Ratios
PEG Ratio-0.75
Price to Book (P/B)0.36
Price to Sales (P/S)0.20
P/FCF Ratio35.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
mDR Limited Business Overview & Revenue Model
Company Description
mDR Limited operates as an investment holding company, primarily involved in the distribution and retail of telecommunication products and services across Singapore and Malaysia. The company's operations are divided into four distinct segments: Af...
mDR Limited Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
49
Neutral
Cash Flow
38
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 248.15M | 232.03M | 215.60M | 175.48M | 189.28M |
| Gross Profit | 39.15M | 40.95M | 32.56M | 27.52M | 24.93M |
| EBITDA | 14.29M | 12.54M | -34.67M | 15.72M | 10.37M |
| Net Income | -795.00K | 5.49M | -42.47M | 7.26M | 4.08M |
Balance Sheet | |||||
| Total Assets | 283.53M | 223.58M | 177.68M | 234.14M | 224.31M |
| Cash, Cash Equivalents and Short-Term Investments | 12.90M | 24.19M | 27.56M | 25.80M | 46.34M |
| Total Debt | 114.37M | 53.07M | 57.08M | 66.33M | 47.77M |
| Total Liabilities | 143.90M | 74.68M | 80.58M | 82.42M | 66.38M |
| Stockholders Equity | 139.14M | 148.43M | 96.62M | 151.23M | 159.38M |
Cash Flow | |||||
| Free Cash Flow | 1.41M | 11.12M | 8.14M | 4.36M | 23.42M |
| Operating Cash Flow | 2.05M | 11.70M | 8.73M | 4.89M | 24.43M |
| Investing Cash Flow | -31.80M | -32.87M | 16.35M | -28.84M | -14.39M |
| Financing Cash Flow | 26.58M | 20.99M | -22.94M | 11.71M | 2.65M |
mDR Limited Technical Analysis
Negative
0.06
Price Trends
0.04
Negative
0.05
Negative
0.06
Negative
Market Momentum
>-0.01
Negative
41.78
Neutral
138.89
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:Y3D, the sentiment is Negative. The current price of 0.06 is above the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.04, and above the 200-day MA of 0.06, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 41.78 is Neutral, neither overbought nor oversold. The STOCH value of 138.89 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:Y3D.
mDR Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | S$1.18B | 28.71 | 6.55% | 1.88% | 8.91% | 5.41% | |
64 Neutral | S$2.93B | 96.86 | 3.48% | ― | 4.98% | 47.27% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | S$530.41M | 77.93 | 16.66% | ― | 53.91% | 157.14% | |
48 Neutral | S$85.85M | -37.00 | 2.22% | 4.10% | 6.95% | -113.73% |
* Technology Sector Average
SG:Y3D
mDR Limited
0.04
-0.04
-49.32%
SG:575
ASTI Holdings Limited
0.12
0.10
735.71%
SG:A31
Addvalue Technologies Ltd
0.14
0.12
781.25%
SG:AWX
AEM Holdings Ltd.
8.64
7.07
451.37%
SG:BDR
Willas-Array Electronics (Holdings) Limited
1.08
0.27
33.33%
SG:E28
Frencken Group Limited
2.63
1.09
70.34%
mDR Limited Corporate Events
mDR Limited Boosts Exposure to Quoted Securities With S$6.3 Million Purchase
Jun 9, 2026
mDR Limited has disclosed that it acquired quoted securities worth about S$6.34 million between 27 May and 5 June 2026, representing 4.6% of its latest audited net tangible assets. Over the same period, the Group sold quoted securities with a hist...
mDR Updates Market on Deployment of Rights Issue Proceeds
Jun 3, 2026
mDR Limited has provided an update on how it has deployed the net proceeds of S$30.6 million raised from its recent rights cum warrants issue, after transaction costs and loan set-offs. The funds are being channeled into working capital and invest...
mDR ramps up trading in quoted securities, reaffirming heavy market exposure
May 29, 2026
mDR Limited has disclosed substantial trading activity in quoted securities between 24 March and 26 May 2026, acquiring investments worth about S$13.7 million and disposing of holdings with a historical cost of approximately S$11.3 million. These ...
mDR shareholders back all resolutions at 25th AGM, reinforcing governance continuity
May 29, 2026
Shareholders of mDR Limited convened for the company’s 25th annual general meeting on 30 April 2026 in Singapore, where the board presented the FY2025 financial results and engaged in an extended question-and-answer session. All resolutions ...
mDR flags bank error in rights issue, revises proceeds and stake projections
May 12, 2026
mDR Limited has disclosed that an inadvertent error by the bank of its undertaking shareholder led to the erroneous sale of 87,347,800 nil-paid rights entitlements on the open market, undermining his ability to fully honour an irrevocable commitme...
mDR Shareholders Back Major Rights-and-Warrants Issue to Boost Capital Base
Apr 29, 2026
Shareholders of mDR Limited have approved a substantial renounceable non-underwritten rights-cum-warrants issue at an extraordinary general meeting held in Singapore on 31 March 2026. The meeting, conducted with electronic polling and overseen by ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.